Evidence map›Paper›PMID 40177406›Full record

ArticleFrontiers in neurology2025

Identifying depression with mixed features: the potential value of eye-tracking features.

Xing-Chang Liu, Ming Chen, Yu-Jia Ji, Hong-Bei Chen, Yu-Qiao Lin, Zhen Xiao, Qiao-Yan Guan, Wan-Qi Ou, Yue-Ya Wang, Qiao-Ling Xiao and 5 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Artificial Intelligence-Based Depression Detection.Sensors (Basel, Switzerland) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xing-Chang Liu *Guangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Ming Chen *Guangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Yu-Jia JiDepartment of Psychiatry, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Hong-Bei ChenGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Yu-Qiao LinGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Zhen XiaoGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Qiao-Yan GuanGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Wan-Qi OuGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Yue-Ya WangGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Qiao-Ling XiaoGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Xin-Cheng-Cheng HuangGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Ji-Fan ZhangGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Ye-Kai HuangGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Qian-Ting YuGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Mei-Jun JiangGuangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the utility of eye-tracking features as a neurobiological marker for identifying depression with mixed features (DMF), a psychiatric disorder characterized by the presence of depressive symptoms alongside subsyndromal manic features, thereby complicating both diagnosis and therapeutic intervention. Methods: A total of 93 participants were included, comprising 41 patients with major depressive disorder (MDD), of whom 20 were classified as DMF, and 52 healthy controls (HC). Eye-tracking features were collected using an infrared-based device, and participants were evaluated using clinical scales including the Montgomery-Åsberg Depression Rating Scale (MADRS), Young Mania Rating Scale (YMRS), and Brief Psychiatric Rating Scale (BPRS). Performance of extreme gradient boosting (XGBoost) model based on demographic and clinical characteristics was compared with that of the model created after adding ocular movement data. Results: Significant differences were observed in certain eye-tracking features between DMF, MDD, and HC, particularly in orienting saccades and overlapping saccades. Incorporating eye-tracking features into the XGBoost model enhanced the predictive accuracy for DMF, as evidenced by an increase in the area under the curve (AUC) from 0.571 to 0.679 ( Conclusion: Eye-tracking features, especially the velocity of overlapping saccades and free viewing task completion time, hold potential as non-invasive biomarkers for the identification of DMF. The integration of these parameters into the XGBoost machine learning model significantly improved the accuracy of DMF diagnosis, offering a promising approach for enhancing clinical decision-making in psychiatric settings.

Indexed as

depressiondiagnosiseye-trackingmachine learningmixed features

Identifiers

PMID40177406
PMCPMC11961420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.